Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

ARMO0000264 - Transmission Report from W J Tarbit to Dr M B Rodell - 20 Jun 1983.pdf [pdf]

Published on: 20 June, 2023

BAYP0000019_080 - Minutes of Cutter Laboratories Board Meeting - 10 Nov 1986.pdf [pdf]

Published on: 20 June, 2023

BAYP0000020_046 - Notes on a meeting between JB and Mr Heath of Speywood Laboratories concerning the Product Licence for Koate.pdf [pdf]

Published on: 20 June, 2023

ARMO0000398 - Letter from R B Christie to Dr P Bell - 04 Jun 1985.pdf [pdf]

Published on: 20 June, 2023

BAYP0004647 - Quality Control of Plasma vs Heat Treatment - 06 Jul 1983.pdf [pdf]

Published on: 20 June, 2023

BAYP0004702_002 - Label for Antihemophilic Factor Human Koate-HT Lyophilized Powder - 18 Nov 1983.pdf [pdf]

Published on: 20 June, 2023

BAYP0000027_078 - Letter from Steven J Ojala to Dr Elaine C Esber - 21 Nov 1983.pdf [pdf]

Published on: 20 June, 2023

ARCH0001710 - Minutes of the meeting of the SubCommittee on Biological Products - 13 Jul 1983.pdf [pdf]

Published on: 20 June, 2023

2020-02-06. Timetable for expert hearings -24 Feb - 28 Feb 20.pdf [pdf]

Published on: 17 February, 2020

BAYP0000022_069 - Department Haematology & Blood Transfusion Blood Products Lab totals 1975 - 01 Jan 1975.pdf [pdf]

Published on: 20 June, 2023

BHCT0000501 - Memo from E J A McCullough to W A Best and J F Browne and S L Has and R Lyons and W McKee and E Bowye - 25 Oct 1984.pdf [pdf]

Published on: 20 June, 2023

BAYP0000024_047 - Memo from B Dyos to M Costi - 30 Jan 1985.pdf [pdf]

Published on: 20 June, 2023

BHCT0000158 - Letter from J H Connolly to Dr E E Mayne - 21 Aug 1985.pdf [pdf]

Published on: 20 June, 2023

BAYP0004952 - Minutes of the Biological Coordinating Committee - 14 Nov 1983.pdf [pdf]

Published on: 20 June, 2023

AMRE0000011_021 - Proposed Research Programme.pdf [pdf]

Published on: 20 June, 2023

BAYP0000028_071 - Cutter Financial Results 1982 and 1983.pdf [pdf]

Published on: 20 June, 2023

BAYP0000019_073 - Cutter Laboratories International Division Preliminary 1982 Marketing Plan - 01 Jan 1982.pdf [pdf]

Published on: 20 June, 2023

BAUM0000012 - Letter from David Ichikawa to Robert Barden - 19 May 1981.pdf [pdf]

Published on: 20 June, 2023

BAYP0000020_014 - Memorandum from J Kris Piper to Lowell Crow - 23 Feb 1976.pdf [pdf]

Published on: 20 June, 2023

BART0002363 - Letter from John L Prothero to Dr B Colvin - 15 Jul 1983.pdf [pdf]

Published on: 20 June, 2023

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 352
  • Page 353
  • Page 354
  • Page 355
  • Current page 356
  • Page 357
  • Page 358
  • Page 359
  • Page 360
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.